LONDON, March 25, 2015 /PRNewswire/ -- Smith &
Nephew (NYSE: SNN) (LSE: SN), the global medical technology
business, today announced the launch of its Q-FIX All-Suture
Anchor. Designed for procedures like rotator cuff repair and labrum
repair in which anatomic space is very limited, the new anchor
delivers performance characteristics that meet or exceed those of
much larger, hard anchors[i].
"The Q-FIX All-Suture Anchor is a great option for hip labral
repair," says J.W. Thomas Byrd, MD
of The Nashville Sports Medicine and Orthopaedic Center in
Nashville, Tenn. "Its small size
allows surgeons to access tight spaces in the hip and the radially
expanding anchor provides exceptionally reliable performance."
Unlike the performance of other all-suture anchors which can
vary based on factors such as poor knot deployment or a surgeon's
ability to fully tension the suture by hand, the Q-FIX implant uses
a unique, radially expanding implant that fully deploys at the same
depth within the bone every time. The Q-FIX anchor also uses an
exclusive deployment dial located on the inserter's handle to
automatically tighten the suture to a target of 140 Newtons - three
times more than is possible using hand tensioning. Insufficient
tensioning can result in micromotion caused by the suture's natural
elasticity, which may reduce anchor performance.
Indicated for use in the shoulder and hip, the Q-FIX anchor is
available in both 1.8mm (single loaded) and 2.8mm (double loaded)
sizes with associated disposable and reusable instruments.
"The Q-FIX implant is the next generation in the design of
all-suture anchors," says Scott
Schaffner, Vice President, Global Sports Medicine Franchise
for Smith & Nephew. "It offers surgeons the benefits and
flexibility they love with all-suture anchors, as well as the
fixation and pull-out strength they expect from much larger, hard
anchors."
Surgeons attending the annual American Academy of Orthopaedic
Surgeons (AAOS) meeting this week in Las
Vegas will be able to learn more about the Q-FIX All-Suture
Anchor at the Smith & Nephew booth #5643.
About Smith & Nephew
Smith & Nephew is a
global medical technology business dedicated to helping healthcare
professionals improve people's lives. With leadership positions in
Orthopaedic Reconstruction, Advanced Wound Management, Sports
Medicine and Trauma & Extremities, Smith & Nephew has
around 14,000 employees and a presence in more than 100 countries.
Annual sales in 2014 were more than $4.6
billion. Smith & Nephew is a member of the FTSE100 (LSE:
SN, NYSE: SNN).
For more information about Smith & Nephew, please visit our
corporate website www.smith-nephew.com, follow @SmithNephewplc on
Twitter or visit SmithNephewplc on Facebook.com
Forward-looking Statements
This document may
contain forward-looking statements that may or may not prove
accurate. For example, statements regarding expected revenue growth
and trading margins, market trends and our product pipeline are
forward-looking statements. Phrases such as "aim", "plan",
"intend", "anticipate", "well-placed", "believe", "estimate",
"expect", "target", "consider" and similar expressions are
generally intended to identify forward-looking statements.
Forward-looking statements involve known and unknown risks,
uncertainties and other important factors that could cause actual
results to differ materially from what is expressed or implied by
the statements. For Smith & Nephew, these factors include:
economic and financial conditions in the markets we serve,
especially those affecting health care providers, payers and
customers; price levels for established and innovative medical
devices; developments in medical technology; regulatory approvals,
reimbursement decisions or other government actions; product
defects or recalls; litigation relating to patent or other claims;
legal compliance risks and related investigative, remedial or
enforcement actions; strategic actions, including acquisitions and
dispositions, our success in performing due diligence, valuing and
integrating acquired businesses; disruption that may result from
transactions or other changes we make in our business plans or
organisation to adapt to market developments; and numerous other
matters that affect us or our markets, including those of a
political, economic, business, competitive or reputational nature.
Please refer to the documents that Smith & Nephew has filed
with the U.S. Securities and Exchange Commission under the U.S.
Securities Exchange Act of 1934, as amended, including Smith &
Nephew's most recent annual report on Form 20-F, for a discussion
of certain of these factors. Any forward-looking statement is based
on information available to Smith & Nephew as of the date of
the statement. All written or oral forward-looking statements
attributable to Smith & Nephew are qualified by this caution.
Smith & Nephew does not undertake any obligation to update or
revise any forward-looking statement to reflect any change in
circumstances or in Smith & Nephew's expectations.
™Trademark of Smith & Nephew. Certain marks
registered US Patent and Trademark Office.
[i] P/N 54231-01 Rev. A; P/N 49193-01 Rev. A; P/N
51963-01 Rev. A
Photo - http://photos.prnewswire.com/prnh/20150324/194195
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/new-q-fix-all-suture-anchor-from-smith--nephew-provides-surgeons-the-pull-out-strength-of-a-hard-implant-in-half-the-space-300055444.html
SOURCE Smith & Nephew